DALLAS, Jan. 16 /PRNewswire-FirstCall/ -- Affiliated Computer Services, Inc. announced today that it has been awarded a seven-year, $130 million contract to provide information technology outsourcing (ITO) services for Allergan, Inc. , a premier, global multi-specialty healthcare company.
Under the terms of the contract, ACS will supply comprehensive infrastructure services, including data center operations, network monitoring and management, and end-user support services. The ACS-designed solution will provide the scale necessary to meet Allergan’s growth, as well as access to new technology to support its unique industry needs.
“This key relationship further expands our presence in the pharmaceutical industry and allows us to develop and strengthen our industry-specific competencies,” said Ann Vezina, group president of ACS Commercial Solutions. “Our partnership will enable Allergan to focus on its global core business operations as the company grows and help meet Allergan’s need for advanced technological capabilities.”
Along with comprehensive ITO services, ACS will implement an innovative platform that utilizes a network connection to store important data online, provide additional data security, and more reliably restore backup data. The solution replicates backup data directly to the disaster recovery site, thereby reducing business recovery time and incidence of data loss by eliminating off-site data handling.
Sue-Jean Lin, Allergan’s Chief Information Officer, said, “With our many innovative products, we operate in a wide range of global, high-growth markets. We needed a strategic partner who could not only support our market-leading positions, but help us meet the challenges of continued expansion. ACS has the technology and expertise to meet our growth needs, and their dedication to quality service makes them a strong cultural fit as well.”
Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential -- to see more clearly, move more freely, express themselves more fully. The Company employs more than 7,500 people worldwide and operates state-of-the-art R&D facilities and world-class manufacturing plants. In addition to its discovery-to-development research organization, Allergan has global marketing and sales capabilities with a presence in more than 100 countries.
ACS, a global FORTUNE 500 company with 62,000 people supporting client operations reaching more than 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The company’s Class A common stock trades on the New York Stock Exchange under the symbol “ACS.” Visit ACS on the Internet at http://www.acs-inc.com.
The statements in this news release that do not directly relate to historical facts constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous risks and uncertainties, many of which are outside the Company’s control. As such, no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward-looking statements. Factors could cause actual results to differ materially from such forward-looking statements. For a description of these factors, see the company’s prior filings with the Securities and Exchange Commission, including our most recent filing. ACS disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future event, or otherwise.
CONTACT: investors, Jon Puckett, Vice President, Investor Relations,
+1-214-841-8281, jon.puckett@acs-inc.com, or media, Tom Clary, Director,
Corporate Communications, +1-214-841-8110, tom.clary@acs-inc.com, both of
Affiliated Computer Services, Inc.
Web site: http://www.acs-inc.com/
